The conference is organised under auspicious of the Polish Academy of Sciences and the Polish Society of Regenerative Medicine.

Conference on “Practical Aspects of Donor-Recipient Matching in HSCT Conference on “Practical Aspects of Donor-Recipient Matching in HSCT Conference on “Practical Aspects of Donor-Recipient Matching in HSCT Conference on “Practical Aspects of Donor-Recipient Matching in HSCT Conference on “Practical Aspects of Donor-Recipient Matching in HSCT

Register now!

All fees for conference registration should be paid in EURO (€) to the Association for the Benefit of Development of Donation of Marrow clearly stating the participant’s name and address by bank transfer.

Conference on “Practical Aspects of Donor-Recipient Matching in HSCT
Conference on “Practical Aspects of Donor-Recipient Matching in HSCT
Conference on “Practical Aspects of Donor-Recipient Matching in HSCT

CONTINUOUSLY TRYING TO BREAK NEW PATHS

Abstracts Online

Deadline for abstract submission has already expired. Accepted abstracts are displayed here.

Learn more

Registration details

Registration at the website is still available. We are cordially inviting you to the conference.

Learn more

Conference news

Click here to have an access to the final conference program.

Learn more

Workshops

Two workshops have already been set up:

1. cytometry of stem cells,

2. ex-vivo propagation of MSC.

Accommodation details

Please make sure that you have already booked hotel accommodation.

Learn more

Travel information

For tourist information, please visit the city website.

Please note the maps.

Tentative Program

Workshop details

I am pleased to inform you that on 17th December 2013, we are going to organize a workshop on the use of cytometry in identification and describing stem cells (SCs), their functional evaluation and finally isolation by sorting. The shown techniques are focusing on mesenchymal, endothelial and very small embryonic-like stem cells. We will focus on right phenotypes of these SC populations, optimal protocols for their isolation and potential pitfalls that may be faced during identification and isolation of such rare cells. The workshop will be run by invited experts in the field in an open manner enabling all participants to follow the procedures and to discuss them with workshop leaders.

Previous informations

Dear Colleagues, The progress in the field of medicine results in the prolongation of human life. This is due to implementation of new technologies bettering the health care delivery, offering medical doctors new instruments and systems supporting life to overcome acute organ impairment. The other line of activity was born from the basic medical science labs in the field of genetics, immunology and medical biology. The latter achievements not only offered new tools (e.g. monoclonal antibodies) but also helped in tailoring the treatment depending on genetic features of some diseases, especially oncological ones. People live longer but they want to enjoy life despite age-dependent degeneration of the organs. Hematopoietic stem cell transplantation, which has already been introduced to routine clinical activity, potentiated the interest of the medical community in stem cells. In a short time it became known that each organ may have its stem cells and that in the marrow exist not only HSC but also marrow stromal cells containing a fraction of cells able to give rise to several tissues built from the mesenchyme. The opinion on the marrow as the natural reservoir of stem cells was further substantiated by the discovery of endothelial stem cells and those described as very small embryonic like cells. The richness of the marrow in stem cells and newly elaborated techniques describing tissue-specific stem cells attracted clinicians to use stem cell therapy in rebuilding damaged tissues. The effectiveness of the latter approach was documented in several clinical situations including the treatment of patients with an infarcted heart and those with critical limb ischemia. Regeneration of several tissues is going to be used as a clinical procedure in orthopedics and oncology. Stem cells, namely mesenchymal stem cells, are also in use to mitigate alloreactivity. Nine thousand papers published in the last three years showed how great is the interest focused on regenerative medicine. However, some hopes are not positively clinically verified in some situations. There are myths and facts [...] Learn more